Minoru Kodama
Directeur/Membre du Conseil chez KAWAMOTO CORPORATION
Profil
Minoru Kodama is currently an Independent Outside Director at Kawamoto Corp.
since 2022.
He is also a Senior Managing Director at Medisa Shinyaku, Inc. since 2008 and a Director at Kaken Shoyaku KK since 2007.
Previously, he worked as a Director, GM-Administration & Deputy GM-Sales at Sawai Pharmaceutical Co., Ltd.
from 2013 to 2018.
He also held a position as Manager-Third Division Screening at UFJ Bank Ltd.
Postes actifs de Minoru Kodama
| Sociétés | Poste | Début |
|---|---|---|
| KAWAMOTO CORPORATION | Directeur/Membre du Conseil | 21/06/2022 |
Medisa Shinyaku, Inc.
 Medisa Shinyaku, Inc. Pharmaceuticals: GenericHealth Technology Part of SAWAI GROUP HOLDINGS Co., Ltd., Medisa Shinyaku, Inc. is a pharmaceutical company based in Osaka, Japan. The company's description is in Japanese, but it appears to be a subsidiary of Sawai Pharmaceutical Co., Ltd. and is involved in the manufacture and sale of pharmaceuticals. The company has been updating its corporate information and has made several announcements regarding its business activities. | Directeur/Membre du Conseil | 01/06/2008 |
| Kaken Shoyaku KK | Directeur/Membre du Conseil | 01/06/2007 |
Anciens postes connus de Minoru Kodama
| Sociétés | Poste | Fin |
|---|---|---|
| UFJ Bank Ltd. | Corporate Officer/Principal | - |
Sawai Pharmaceutical Co., Ltd.
 Sawai Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Sawai Pharmaceutical Co., Ltd. engages in the manufacture and sale of prescription pharmaceutical products. Its products include cardiovascular drugs, antihyperlipidemic agents, diabetes, anticancer drugs, and over-the-counter drugs. It operates through the Japan and United States segments. The Japan segment sells manufactured pharmaceuticals to domestic sales companies, wholesale stores and other pharmaceutical manufacturers, as well as directly to medical institutions. The United States segment comprises of holding companies that manages subsidiaries and sell manufactured pharmaceuticals to wholesale stores in the United States. The company was founded by Hanpei Sawai and Noyo Sawai on April 1, 1929 and is headquartered in Osaka, Japan. | Directeur Administratif | 26/06/2018 |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| KAWAMOTO CORPORATION | Health Technology |
| Entreprise privées | 4 |
|---|---|
Sawai Pharmaceutical Co., Ltd.
Sawai Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Sawai Pharmaceutical Co., Ltd. engages in the manufacture and sale of prescription pharmaceutical products. Its products include cardiovascular drugs, antihyperlipidemic agents, diabetes, anticancer drugs, and over-the-counter drugs. It operates through the Japan and United States segments. The Japan segment sells manufactured pharmaceuticals to domestic sales companies, wholesale stores and other pharmaceutical manufacturers, as well as directly to medical institutions. The United States segment comprises of holding companies that manages subsidiaries and sell manufactured pharmaceuticals to wholesale stores in the United States. The company was founded by Hanpei Sawai and Noyo Sawai on April 1, 1929 and is headquartered in Osaka, Japan. | Health Technology |
| UFJ Bank Ltd. | Finance |
Medisa Shinyaku, Inc.
Medisa Shinyaku, Inc. Pharmaceuticals: GenericHealth Technology Part of SAWAI GROUP HOLDINGS Co., Ltd., Medisa Shinyaku, Inc. is a pharmaceutical company based in Osaka, Japan. The company's description is in Japanese, but it appears to be a subsidiary of Sawai Pharmaceutical Co., Ltd. and is involved in the manufacture and sale of pharmaceuticals. The company has been updating its corporate information and has made several announcements regarding its business activities. | Health Technology |
| Kaken Shoyaku KK |
